Study Finds Infliximab Biosimilar Switch Is Safe, Effective for Patients with IBD HCP Live, 24 Oct 2023 Credit: Unsplash For patients with inflammatory bowel disease (IBD), switching the infliximab biosimilars CT-P13 to SB2 is safe…